Public source
Reviewed 10 Oct 2026
Completeness Good (42%)
DiaKwant™ HER2
DiaDeepThe DiaKwant™ HER2 algorithms assist pathologists in evaluating hormonal and proliferative biomarkers.
"DiaKwant™ detects invasive tumor regions and performs cell- and membrane-level analysis on IHC slides. The algorithm quantifies staining intensity (0, 1+, 2+, 3+) and membrane completeness across tumor cells, providing an interpretable whole-slide HER2 score in line with ASCO/CAP and GEFPICS guidelines."(https://www.diadeep.com/diakwant)
The DiaKwant™ consists of several algorithms that are a part of a single CE-IVD validated solution.
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Subspeciality
Organ/Specimen source
Disease targeted
Specimen type
Not specified
Staining
Stain subtype
Regulatory Information
Pathway:
In Vitro Diagnostic Regulation (IVDR)
Class:
Class C
Not verified by Health AI Register
Scanner Brands Certified for Use (CE-IVD)
Not specified
Scanner Models Certified for Use (CE-IVD)
Not specified
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Deployment
Not specified
Trigger for analysis
Not specified
Processing time
Not specified
Population
Viewer systems
Not specified
Market Presence
On market since
AI Platforms
Resellers
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Public | First published: Oct 10, 2026 | Last updated: Oct 10, 2026